Pacific Biosciences of California
Logotype for Pacific Biosciences of California Inc

Pacific Biosciences of California (PACB) investor relations material

Pacific Biosciences of California 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Pacific Biosciences of California Inc
44th Annual J.P. Morgan Healthcare Conference summary12 Jan, 2026

Business and Market Overview

  • Focused on advanced, highly accurate long-read sequencing solutions, with over 80 products and 60% launched in the last three years.

  • Targeting a ~$9B market by 2028, growing at 7% annually, with key segments in clinical, rare disease, oncology, carrier screening, and discovery.

  • Clinical and population sequencing are primary growth drivers, with clinical segment being the fastest growing and under-penetrated in rare disease and oncology.

  • Strategic vision is to enable genomics to improve human health through advanced sequencing technologies.

Financial Performance and Growth

  • 2025 revenue reached ~$160M, up 4%, with Q4 revenue of ~$44.6M and cash/investments of ~$280M.

  • Record consumables sales in three of four quarters, with consumables driving both revenue and gross margin.

  • Human-focused consumable shipments grew 19% in 2025; three-year human CAGR at 23%.

  • 210 total instrument placements in 2025, driven by strong clinical and hospital traction.

  • Cash burn reduced to $110M in 2025.

Platform Performance and Innovation

  • Revio system saw 61 placements in 2025, with ~$334M in shipments since 2023 and a 22% yield improvement.

  • Vega system launched end of 2024, with 140 placements in 2025; 65% to new customers.

  • SPRQ chemistry to be launched on Vega in 2026, increasing throughput and lowering costs.

  • SPRQ Next Chemistry allows multi-use SMRT cells, reducing costs and increasing throughput by 25%.

  • Whole genome sequencing now priced at or below $300/genome, making HiFi competitive with short-read technologies.

SPRQ-Nx: How does it challenge short-read dominance?
What drives clinical scale-up beyond initial adoption?
How will HiFi data and AI enable digital diagnostics?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Pacific Biosciences of California earnings date

Logotype for Pacific Biosciences of California Inc
Q4 202513 Feb, 2026
Pacific Biosciences of California
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Pacific Biosciences of California earnings date

Logotype for Pacific Biosciences of California Inc
Q4 202513 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT™) Sequencing platform enables single molecule real-time detection of biological processes. Its SMRT Sequencing technology provides various applications, including de novo sequencing to assemble a genome from scratch; targeted sequencing to sample specific regions of interest; and epigenetic sequencing to study how environmental factors affect gene expression. It has collaboration with Cold Spring Harbor Laboratory to expand its efforts in developing third-generation DNA sequencing technology.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage